Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the ...

HERZLIYA, Israel and CALGARY, Alberta, Jan. 9, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical ...

A new in vitro study found that cannabidiol (CBD) may effectively treat colorectal cancer, regardless of mutation. | Cannabis Sciences ...

Cannabidiol is under clinical development by Jazz Pharmaceuticals and currently in Phase II for Schizophrenia.

NAUGATUCK - A Bethlehem woman who gave marijuana-laced gummies to Naugatuck High School students was denied a special ...

Cannabidiol (CBD) is safe and may reduce anxiety levels two to four hours after ingestion, according to a study.

When discussing health implications of unregulated THC, Dr. Weis acknowledged potential dangers but expressed skepticism on ...

A pack of gummy bears may have lifted your spirits as a kid, but these days, some gummies are claiming to lift a lot more.

The contents of cannabis plants are both psychoactive and nutritious. Today, extracts from the cannabis plant are ingredients ...

The global cannabidiol oil market size was US$ 3.57 billion in 2021. The global cannabidiol oil market is forecast to grow to US$ 16.3 billion by 2030 by registering a compound annual growth rate ...

However, a new study examines whether cannabidiol (CBD), a non-psychoactive compound derived from the cannabis plant, could be a promising solution for alleviating scan-related anxiety.